ÆÄÀÌÇÁ¶óÀÎ ºÐ¼® ½ÃÀåÁ¶»çº¸°í¼­

ÆÄÀÌÇÁ¶óÀÎ ºÐ¼® ½ÃÀåÀ» Á¶»ç ºÐ¼®ÇÑ ÀÚ·á·Î ½ÃÀå±Ô¸ð, »ê¾÷ºÐ¼®, ÇâÈÄ ½ÃÀå¿¹Ãø µîÀÇ ³»¿ëÀ» ´Ù·ç°í ÀÖ½À´Ï´Ù.

1 - 25 (Àüü: 509°Ç)
ÀÀ°íÀÎÀÚ °áÇÌÁõ ½ÃÀå - ¼¼°è ¹× Áö¿ªº° ºÐ¼® : °áÇÌÁõ À¯Çüº°, Á¦Ç° À¯Çüº°, ÃÖÁ¾»ç¿ëÀÚº°, Áö¿ªº° - ºÐ¼®°ú ¿¹Ãø(2025-2035³â)
Coagulation Factor Deficiency Market - A Global and Regional Analysis: Focus on Deficiency Type, Product Type, End-User, and Region - Analysis and Forecast, 2025-2035
¹ßÇà 2025³â 06¿ù
°¡°Ý US $ 4,900 £Ü 6,718,000 (ºÎ°¡¼¼ º°µµ)
ÀÌ¸í ½ÃÀå - ¼¼°è ¹× Áö¿ªº° ºÐ¼® : Åõ¿© °æ·Îº°, À¯Çüº°, ¾à¹° Á¾·ùº°, À¯Åë ä³Îº°, ±¹°¡º°, Áö¿ªº° - ºÐ¼®°ú ¿¹Ãø(2025-2035³â)
Tinnitus Market - A Global and Regional Analysis: Focus on Route of Administration, Type, Drug Class, Distribution Channel, Country, and Region - Analysis and Forecast, 2025-2035
¹ßÇà 2025³â 06¿ù
°¡°Ý US $ 4,900 £Ü 6,718,000 (ºÎ°¡¼¼ º°µµ)
¿¦Æ¼ÇǹÙŸÀ̵å(Eptifibatide) ½ÃÀå º¸°í¼­ : µ¿Çâ, ¿¹Ãø, °æÀï ºÐ¼®(-2031³â)
Eptifibatide Market Report: Trends, Forecast and Competitive Analysis to 2031
¹ßÇà 2025³â 06¿ù
°¡°Ý US $ 3,850 £Ü 5,278,000 (ºÎ°¡¼¼ º°µµ)
¼¼Æ÷³» Ä®½· ½ÅÈ£Àü´Þ ½Ã½ºÅÛ ½ÃÀå º¸°í¼­ : µ¿Çâ, ¿¹Ãø, °æÀï ºÐ¼®(-2031³â)
Intracellular Calcium Signaling System Market Report: Trends, Forecast and Competitive Analysis to 2031
¹ßÇà 2025³â 06¿ù
°¡°Ý US $ 3,850 £Ü 5,278,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ GLP-1 À¯»çü ½ÃÀå
GLP-1 Analogues
¹ßÇà 2025³â 06¿ù
°¡°Ý US $ 5,850 £Ü 8,020,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ ¾î¼Å ÁõÈıº ½ÃÀå º¸°í¼­(2025³â)
Usher Syndrome Global Market Report 2025
¹ßÇà 2025³â 06¿ù
°¡°Ý US $ 4,490 £Ü 6,156,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ »êÇʸ®Æ÷ ÁõÈıº ½ÃÀå º¸°í¼­(2025³â)
Sanfilippo Syndrome Global Market Report 2025
¹ßÇà 2025³â 06¿ù
°¡°Ý US $ 4,490 £Ü 6,156,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ ÇÁ·ÎÅ׿콺 ÁõÈıº ½ÃÀå º¸°í¼­(2025³â)
Proteus Syndrome Global Market Report 2025
¹ßÇà 2025³â 06¿ù
°¡°Ý US $ 4,490 £Ü 6,156,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ ¿åâ ½ÃÀå º¸°í¼­(2025³â)
Pressure Ulcers Global Market Report 2025
¹ßÇà 2025³â 06¿ù
°¡°Ý US $ 4,490 £Ü 6,156,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ µµÆÄ¹Î ÀÛ¿ëÁ¦ ½ÃÀå º¸°í¼­(2025³â)
Dopamine Agonists Global Market Report 2025
¹ßÇà 2025³â 06¿ù
°¡°Ý US $ 4,490 £Ü 6,156,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ ³»Áø ÀåÄ¡ ½ÃÀå
Tremor Proof Devices
¹ßÇà 2025³â 06¿ù
°¡°Ý US $ 5,850 £Ü 8,020,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ ÀÎÅ×±×¶óÁ¦ ¾ïÁ¦Á¦ ½ÃÀå
Integrase Inhibitors
¹ßÇà 2025³â 06¿ù
°¡°Ý US $ 5,850 £Ü 8,020,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ °£Áú¼º ¹æ±¤¿° Ä¡·áÁ¦ ½ÃÀå
Interstitial Cystitis Drugs
¹ßÇà 2025³â 06¿ù
°¡°Ý US $ 5,850 £Ü 8,020,000 (ºÎ°¡¼¼ º°µµ)
¿åâ Ä¡·á ½ÃÀå : ½ÃÀå ±Ô¸ð, Á¡À¯À², µ¿Çâ, ¿¹Ãø - ±Ë¾ç À¯Çüº°, Á¦Ç° À¯Çüº°, ÃÖÁ¾ »ç¿ëÀÚº°, Áö¿ªº°(2025-2033³â)
Pressure Ulcers Treatment Market Size, Share, Trends and Forecast by Ulcer Type, Product Type, End User, and Region, 2025-2033
¹ßÇà 2025³â 06¿ù
°¡°Ý US $ 2,999 £Ü 4,111,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ NADPH ¿Á½Ã´Ù¾ÆÁ¦(NOX) ´ëü ¿ä¹ý ½ÃÀå : ´ë»ó ȯÀÚ, °æÀï ±¸µµ, ½ÃÀå ¿¹Ãø(2034³â)
NADPH Oxidase (NOX)-Replacement Therapies - Target Population, Competitive Landscape, and Market Forecast - 2034
¹ßÇà 2025³â 06¿ù
°¡°Ý US $ 7,950 £Ü 10,900,000 (ºÎ°¡¼¼ º°µµ)
GPCR Ç¥Àû Ä¡·áÁ¦ : Ç¥Àû Áý´Ü, °æÀï ±¸µµ, ½ÃÀå ¿¹Ãø(2034³â)
GPCR-Targeting Therapies - Target Population, Competitive Landscape, and Market Forecast - 2034
¹ßÇà 2025³â 06¿ù
°¡°Ý US $ 7,950 £Ü 10,900,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ µðÇÏÀ̵å·Î¿À·Îƾ»ê Å»¼ö¼ÒÈ¿¼Ò(DHODH) ¾ïÁ¦Á¦ ½ÃÀå : ´ë»ó ȯÀÚ Áý´Ü, °æÀï ±¸µµ, ¿¹Ãø(-2034³â)
Dihydroorotate Dehydrogenase (DHODH) Inhibitor- Target Population, Competitive Landscape, and Market Forecast - 2034
¹ßÇà 2025³â 06¿ù
°¡°Ý US $ 7,950 £Ü 10,900,000 (ºÎ°¡¼¼ º°µµ)
Ƽ·Î½Å Ű³ª¾ÆÁ¦ 2(TYK2) ÀúÇØÁ¦ : Ç¥Àû Áý´Ü, °æÀï ±¸µµ, ½ÃÀå ¿¹Ãø(2034³â)
Tyrosine kinase 2 (TYK2) Inhibitors - Target Population, Competitive Landscape, and Market Forecast - 2034
¹ßÇà 2025³â 06¿ù
°¡°Ý US $ 7,950 £Ü 10,900,000 (ºÎ°¡¼¼ º°µµ)
¸²ÇÁ±¸ Ȱ¼ºÈ­ À¯ÀüÀÚ 3(LAG-3) : Ç¥Àû Áý´Ü, °æÀï ±¸µµ, ½ÃÀå ¿¹Ãø(2034³â)
Lymphocyte-Activation Gene 3 (LAG-3) -Target Population, Competitive Landscape, and Market Forecast-2034
¹ßÇà 2025³â 06¿ù
°¡°Ý US $ 7,950 £Ü 10,900,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ ROS-1 ¾ïÁ¦Á¦ ½ÃÀå : ´ë»ó ȯÀÚ Áý´Ü, °æÀï ±¸µµ, ½ÃÀå ¿¹Ãø(-2034³â)
ROS Proto-oncogene 1 (ROS-1) Inhibitors -Target Population, Competitive Landscape, and Market Forecast-2034
¹ßÇà 2025³â 06¿ù
°¡°Ý US $ 7,950 £Ü 10,900,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ ÀÎÅÍ·ùŲ-2 ½ÃÀå : Áö¿ªº° ºÐ¼®°ú ¿¹Ãø(2025-2035³â)
Interleukin-2 Market - A Global and Regional Analysis: Analysis and Forecast, 2025-2035
¹ßÇà 2025³â 05¿ù
°¡°Ý US $ 4,900 £Ü 6,718,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ ½Â¸ðÆÇ Áúȯ ½ÃÀå
Mitral Valve Diseases
¹ßÇà 2025³â 05¿ù
°¡°Ý US $ 5,850 £Ü 8,020,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ ½Â¸ðÆÇ Áúȯ Ä¡·áÁ¦ ½ÃÀå
Mitral Valve Disease Therapeutics
¹ßÇà 2025³â 05¿ù
°¡°Ý US $ 5,850 £Ü 8,020,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ °íÀλêÇ÷Áõ ½ÃÀå : Áö¿ªº° ºÐ¼® ¹× ¿¹Ãø(2025-2035³â)
Hyperphosphatemia Market - A Global and Regional Analysis: Analysis and Forecast, 2025-2035
¹ßÇà 2025³â 05¿ù
°¡°Ý US $ 4,900 £Ü 6,718,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ º»Å¼º ÁøÀü ½ÃÀå º¸°í¼­ : µ¿Çâ, ¿¹Ãø, °æÀï ºÐ¼®(-2031³â)
Essential Tremor Market Report: Trends, Forecast and Competitive Analysis to 2031
¹ßÇà 2025³â 05¿ù
°¡°Ý US $ 3,850 £Ü 5,278,000 (ºÎ°¡¼¼ º°µµ)
(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.